Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2022 | 1 |
2023 | 1 |
2024 | 1 |
Search Results
2 results
Results by year
Filters applied: . Clear all
Page 1
Safety and immunogenicity of a simian-adenovirus-vectored rabies vaccine: an open-label, non-randomised, dose-escalation, first-in-human, single-centre, phase 1 clinical trial.
Lancet Microbe. 2022 Sep;3(9):e663-e671. doi: 10.1016/S2666-5247(22)00126-4. Epub 2022 Jul 27.
Lancet Microbe. 2022.
PMID: 35907430
Free PMC article.
Clinical Trial.
Accelerated and intensified manufacturing of an adenovirus-vectored vaccine to enable rapid outbreak response.
Joe CCD, Segireddy RR, Oliveira C, Berg A, Li Y, Doultsinos D, Scholze S, Ahmad A, Nestola P, Niemann J, Douglas AD.
Joe CCD, et al.
Biotechnol Bioeng. 2024 Jan;121(1):176-191. doi: 10.1002/bit.28553. Epub 2023 Sep 25.
Biotechnol Bioeng. 2024.
PMID: 37747758
Free PMC article.
Item in Clipboard
Cite
Cite